Cite
HARVARD Citation
Lee, H. et al. (2016). A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea. Medicine. 96 (1), p. . [Online].